Fundraising Fox
VERO Biotech
226 employees on LinkedIn · 4 known investors
Find your way into VERO Biotech
Sign up to see every warm intro you have to VERO Biotech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the VERO Biotech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
VERO Biotech develops next-generation inhaled nitric oxide (iNO) delivery systems for patients with cardiopulmonary conditions in acute care hospital settings. The company focuses on designing and commercializing innovative medical devices to address unmet clinical needs.
Investors · 4
Brace Pharmalisted by Brace PharmaAtlanta
How we know: Brace Pharma's portfolio page · Not right? Tell us
Runway Growth Capitallisted by Runway Growth CapitalMenlo Park
How we know: Runway Growth Capital's portfolio page · funding news · press coverage · Not right? Tell us
MVM Life Science PartnersreportedLondon · $20M – $100M
How we know: press coverage · Not right? Tell us
Also in the syndicate · 1
Petrichorlead
Related companies · 2
Vero BioscienceVero BioScience develops a blood-based proteomic test that measures organ-specific protein signatures to assess the biological age of individual organs and detect early signs of age-related disease. The company targets individuals seeking predictive health insights and preventive medicine interventions based on technology developed at Stanford.
PreqinPreqin provides a data and intelligence platform for investment teams, M&A professionals, and corporate development teams to source, evaluate, and value private company investments through integrated asset, fund, and performance data.
Companies working in the same space as VERO Biotech.
In the news
Frequently asked questions
- What does VERO Biotech do?
- VERO Biotech develops next-generation inhaled nitric oxide (iNO) delivery systems for patients with cardiopulmonary conditions in acute care hospital settings. The company focuses on designing and commercializing innovative medical devices to address unmet clinical needs.
- Who are VERO Biotech's investors?
- VERO Biotech's investors include Brace Pharma, Runway Growth Capital, MVM Life Science Partners.